Cho, C.-F.; Farquhar, C.E.; Fadzen, C.M.; Scott, B.; Zhuang, P.; von Spreckelsen, N.; Loas, A.; Hartrampf, N.; Pentelute, B.L.; Lawler, S.E.
A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma. Cancers 2022, 14, 2207.
https://doi.org/10.3390/cancers14092207
AMA Style
Cho C-F, Farquhar CE, Fadzen CM, Scott B, Zhuang P, von Spreckelsen N, Loas A, Hartrampf N, Pentelute BL, Lawler SE.
A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma. Cancers. 2022; 14(9):2207.
https://doi.org/10.3390/cancers14092207
Chicago/Turabian Style
Cho, Choi-Fong, Charlotte E. Farquhar, Colin M. Fadzen, Benjamin Scott, Pei Zhuang, Niklas von Spreckelsen, Andrei Loas, Nina Hartrampf, Bradley L. Pentelute, and Sean E. Lawler.
2022. "A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma" Cancers 14, no. 9: 2207.
https://doi.org/10.3390/cancers14092207
APA Style
Cho, C.-F., Farquhar, C. E., Fadzen, C. M., Scott, B., Zhuang, P., von Spreckelsen, N., Loas, A., Hartrampf, N., Pentelute, B. L., & Lawler, S. E.
(2022). A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma. Cancers, 14(9), 2207.
https://doi.org/10.3390/cancers14092207